| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662396248P | 2016-09-19 | 2016-09-19 | |
| US201662437685P | 2016-12-22 | 2016-12-22 | |
| PCT/EP2017/073622WO2018050916A1 (en) | 2016-09-19 | 2017-09-19 | Polymer-free drug eluting vascular stents |
| Publication Number | Publication Date |
|---|---|
| SG11201900602XAtrue SG11201900602XA (en) | 2019-02-27 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201900602XASG11201900602XA (en) | 2016-09-19 | 2017-09-19 | Polymer-free drug eluting vascular stents |
| Country | Link |
|---|---|
| US (1) | US20190388210A1 (en) |
| EP (1) | EP3515517B1 (en) |
| JP (1) | JP7074747B2 (en) |
| KR (1) | KR102459201B1 (en) |
| CN (1) | CN109715224B (en) |
| AU (1) | AU2017328714B2 (en) |
| SG (1) | SG11201900602XA (en) |
| WO (1) | WO2018050916A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3558407B1 (en)* | 2016-12-22 | 2023-03-15 | Biotronik AG | Drug releasing coatings for medical devices and methods of making same |
| JP7005742B2 (en)* | 2017-07-26 | 2022-01-24 | 鼎科医療技術(蘇州)有限公司 | Surface liquefied drug coated balloon |
| EP3613449A1 (en)* | 2018-08-23 | 2020-02-26 | Biotronik Ag | Improvement of the polymer layer in degradable devices |
| JP7641222B2 (en)* | 2019-01-30 | 2025-03-06 | バイオトロニック アクチェンゲゼルシャフト | Covered stents for localized drug delivery |
| CN110441193A (en)* | 2019-07-31 | 2019-11-12 | 山东吉威医疗制品有限公司 | A kind of non-polymer medication coat FirebirdTM carries the measuring method of medicine density |
| JP7481134B2 (en)* | 2019-12-20 | 2024-05-10 | イビデン株式会社 | Plant activators |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5527337A (en) | 1987-06-25 | 1996-06-18 | Duke University | Bioabsorbable stent and method of making the same |
| US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6013853A (en) | 1992-02-14 | 2000-01-11 | The University Of Texas System | Continuous release polymeric implant carrier |
| US5288711A (en) | 1992-04-28 | 1994-02-22 | American Home Products Corporation | Method of treating hyperproliferative vascular disease |
| US5342348A (en) | 1992-12-04 | 1994-08-30 | Kaplan Aaron V | Method and device for treating and enlarging body lumens |
| US5824048A (en) | 1993-04-26 | 1998-10-20 | Medtronic, Inc. | Method for delivering a therapeutic substance to a body lumen |
| US5707385A (en) | 1994-11-16 | 1998-01-13 | Advanced Cardiovascular Systems, Inc. | Drug loaded elastic membrane and method for delivery |
| US6099562A (en) | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
| CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
| GB9606452D0 (en) | 1996-03-27 | 1996-06-05 | Sandoz Ltd | Organic compounds |
| EP1003444A4 (en) | 1997-08-08 | 2004-07-28 | Sunscope International Inc | Microporous stent and implantation device |
| US6159488A (en) | 1997-08-14 | 2000-12-12 | Agricultural Research Org. Ministry Of Agriculture (Gov.) | Intracoronary stents containing quinazolinone derivatives |
| US6153252A (en) | 1998-06-30 | 2000-11-28 | Ethicon, Inc. | Process for coating stents |
| US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
| AU2458501A (en)* | 2000-01-05 | 2001-07-16 | Imarx Therapeutics, Inc. | Pharmaceutical formulations for the delivery of drugs having low aqueous solubility |
| US7357854B1 (en)* | 2002-08-19 | 2008-04-15 | Advanced Cardiovascular Systems, Inc. | Process for electropolishing a device made from cobalt-chromium |
| US7901451B2 (en)* | 2004-09-24 | 2011-03-08 | Biosensors International Group, Ltd. | Drug-delivery endovascular stent and method for treating restenosis |
| US8124127B2 (en)* | 2005-10-15 | 2012-02-28 | Atrium Medical Corporation | Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings |
| US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| US20060127443A1 (en)* | 2004-12-09 | 2006-06-15 | Helmus Michael N | Medical devices having vapor deposited nanoporous coatings for controlled therapeutic agent delivery |
| US20070104753A1 (en)* | 2005-11-04 | 2007-05-10 | Aiden Flanagan | Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s) |
| US20080175887A1 (en)* | 2006-11-20 | 2008-07-24 | Lixiao Wang | Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs |
| US8273402B2 (en)* | 2007-02-26 | 2012-09-25 | Medtronic Vascular, Inc. | Drug coated stent with magnesium topcoat |
| US20080243241A1 (en)* | 2007-03-28 | 2008-10-02 | Zhao Jonathon Z | Short term sustained drug-delivery system for implantable medical devices and method of making the same |
| US9327060B2 (en)* | 2009-07-09 | 2016-05-03 | CARDINAL HEALTH SWITZERLAND 515 GmbH | Rapamycin reservoir eluting stent |
| BR112012006925A2 (en)* | 2009-10-16 | 2016-06-07 | Hemoteq Ag | use of a composition containing at least one solvent, at least one pharmacological agent and a transport mediator or a mixture of transport mediators, method for coating balloon catheters and balloon catheters |
| DE102010022588A1 (en)* | 2010-05-27 | 2011-12-01 | Hemoteq Ag | Balloon catheter with a particle-free drug-releasing coating |
| US9056152B2 (en)* | 2011-08-25 | 2015-06-16 | Boston Scientific Scimed, Inc. | Medical device with crystalline drug coating |
| CN102397119A (en)* | 2011-09-29 | 2012-04-04 | 微创医疗器械(上海)有限公司 | Interventional medical instrument and preparation method thereof |
| WO2013091722A1 (en)* | 2011-12-23 | 2013-06-27 | Innora Gmbh | Drug-coated medical devices |
| DK2859001T3 (en)* | 2012-06-08 | 2016-05-30 | Biotronik Ag | RAPAMYCIN 40-O-CYCLIC HYDROCARBESTERS, COMPOSITIONS AND PROCEDURES |
| CN104524646A (en)* | 2014-06-03 | 2015-04-22 | 东莞天天向上医疗科技有限公司 | Biodegradable drug eluting stent and manufacturing method thereof |
| Publication number | Publication date |
|---|---|
| AU2017328714A1 (en) | 2019-01-24 |
| AU2017328714B2 (en) | 2022-05-12 |
| CN109715224B (en) | 2022-02-22 |
| JP7074747B2 (en) | 2022-05-24 |
| KR20190057059A (en) | 2019-05-27 |
| EP3515517B1 (en) | 2022-02-16 |
| JP2019528889A (en) | 2019-10-17 |
| WO2018050916A1 (en) | 2018-03-22 |
| US20190388210A1 (en) | 2019-12-26 |
| EP3515517A1 (en) | 2019-07-31 |
| KR102459201B1 (en) | 2022-10-27 |
| CN109715224A (en) | 2019-05-03 |
| Publication | Publication Date | Title |
|---|---|---|
| SG11201900602XA (en) | Polymer-free drug eluting vascular stents | |
| SG11201805570WA (en) | Systems and methods for long term transdermal administration | |
| SG11201408092UA (en) | Endoprosthesis and delivery device for implanting such endoprosthesis | |
| SG11201806340YA (en) | Zika virus vaccine | |
| SG11201906297QA (en) | Nucleic acids encoding crispr-associated proteins and uses thereof | |
| SG11201900163PA (en) | Macrocycle kinase inhibitors | |
| SG11201811431VA (en) | Multispecific antibodies against cd40 and cd137 | |
| SG11201901442RA (en) | Heart valve docking coils and systems | |
| SG11201805320XA (en) | Materials and methods for treatment of amyotrophic lateral sclerosis and/or frontal temporal lobular degeneration | |
| SG11201901390TA (en) | Tetracycline compounds and methods of treatment | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201908326YA (en) | Methods of treating neurodegenerative diseases | |
| SG11201907889YA (en) | Glycan-interacting compounds and methods of use | |
| SG11201810485SA (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
| SG11202000136YA (en) | Preparation comprising vonoprazan | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201811221XA (en) | Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof | |
| CA3025288C (en) | Reduced misting alkaline and neutral cleaning, sanitizing, and disinfecting compositions via the use of high molecular weight water-in-oil emulsion polymers | |
| SG11201808306PA (en) | Treatment of cancer with tg02 | |
| SG11201810280YA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900554YA (en) | Spiro-lactam nmda modulators and methods of using same | |
| SG11201809531SA (en) | BINDING MOLECULES SPECIFIC FOR FCγGAMMA RIIA AND USES THEREOF | |
| SG11201809875VA (en) | Compositions and methods for treating spinal muscular atrophy | |
| SG11201901188VA (en) | Metal powder feedstocks for additive manufacturing, and system and methods for producing the same | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof |